Stock Events

Stock Events

Renalytix 

€0.01
0
-€0-0% Today

Statistics

Day High
0.02
Day Low
0.01
52W High
0.11
52W Low
0.01
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2O9.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories offers a range of products for the clinical diagnostics market, competing in the same space as Renalytix's kidney diagnostic solutions.
Quest Diagnostics
DGX
Mkt Cap22.03B
Quest Diagnostics provides diagnostic testing, information, and services, including for kidney function, directly competing with Renalytix's offerings.
Labcorp
LH
Mkt Cap22.69B
Laboratory Corporation of America Holdings operates in the same clinical laboratory services sector, offering tests that overlap with Renalytix's kidney health diagnostics.
Exact Sciences
EXAS
Mkt Cap20.03B
Exact Sciences Corp focuses on the detection of cancer, but its expansion into broader diagnostic solutions presents competition for Renalytix's diagnostic tests.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health operates in the precision oncology field but competes with Renalytix through its development of diagnostics that could overlap with kidney disease detection.
Fulgent Genetics
FLGT
Mkt Cap525.3M
Fulgent Genetics provides comprehensive genetic testing, directly competing in the genetic markers space for diseases, including those related to the kidney.
QuidelOrtho
QDEL
Mkt Cap1.17B
QuidelOrtho Corporation is a provider of diagnostic testing solutions that compete with Renalytix by offering tests that can be used in diagnosing kidney conditions.
Neogenomics
NEO
Mkt Cap1.04B
NeoGenomics specializes in cancer diagnostics and testing services but competes with Renalytix by offering tests that could be relevant for kidney disease patients.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific offers a wide range of healthcare solutions, including diagnostics that compete with Renalytix's kidney disease diagnostic products.

About

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. The company's products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. It has a license agreement with Mount Sinai Health System to develop and commercialize its products in connection with the application of artificial intelligence for the diagnosis of kidney disease. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. The company was incorporated in 2018 and is based in London, the United Kingdom.
Show more...
CEO
Mr. James R. McCullough M.B.A.
Employees
46
Country
DE
ISIN
GB00BYWL4Y04

Listings

OTC Link
US
RENXF
STU
DE
2O90.STU
STU
DE
2O9.STU
OTC Link
US
RNLXY

0 Comments

Share your thoughts

FAQ

What is Renalytix stock price today?▼
The current price of 2O9.STU is €0.01 EUR — it has decreased by -0% in the past 24 hours. Watch Renalytix stock price performance more closely on the chart.
What is Renalytix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Renalytix stocks are traded under the ticker 2O9.STU.
Is Renalytix stock price growing?▼
2O9.STU stock has fallen by -6.9% compared to the previous week, the month change is a -64.47% fall, over the last year Renalytix has showed a -83.02% decrease.
How many employees does Renalytix have?▼
As of April 10, 2026, the company has 46 employees.
In which sector is Renalytix located?▼
Renalytix operates in the Health Care sector.
When did Renalytix complete a stock split?▼
Renalytix has not had any recent stock splits.
Where is Renalytix headquartered?▼
Renalytix is headquartered in London, DE.